CHP2 Activators
The class of CHP2 activators, as of the latest information available, does not include specific chemicals that directly target Calcineurin B Homologous Protein 2. Instead, the focus is on compounds that can generally affect calcium signaling and ion channel functions, thereby potentially influencing the function or expression of CHP2 indirectly. Calcium channel blockers and antagonists like Verapamil, Nifedipine, and Amlodipine can modulate calcium influx, which could indirectly impact calcium-dependent regulatory processes involving CHP2.
Agents like Ryanodine and Thapsigargin, which modulate calcium release from intracellular stores, could have implications for calcium signaling pathways relevant to CHP2's function. While these compounds can provide insights into calcium signaling mechanisms and ion transport regulation, their specific effects on CHP2 are not well-established. Therefore, targeted research and development are necessary to discover direct activators or specific modulators for CHP2, contributing to a more precise understanding of its biological functions and potential roles in calcium-dependent cellular processes.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
A calcium channel blocker, could indirectly affect calcium signaling pathways involving CHP2. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Another calcium channel blocker, potentially influencing calcium-dependent processes related to CHP2. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $73.00 $163.00 | 2 | |
A calcium channel antagonist, might have indirect effects on calcium signaling and CHP2 function. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
A calcium channel blocker, potentially impacting calcium-dependent pathways and CHP2 activity. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $60.00 $301.00 | 2 | |
Used for cerebral vasospasm, affects calcium channels and could influence CHP2-related signaling. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $219.00 $765.00 | 19 | |
Modulates calcium release from sarcoplasmic/endoplasmic reticulum, potentially affecting CHP2 functions. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
A SERCA pump inhibitor, elevates cytosolic calcium levels, potentially impacting CHP2-related activities. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
A known modulator of calcium signaling, could indirectly affect pathways involving CHP2. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
Modulates intracellular calcium release, potentially influencing CHP2 functions. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $92.00 $348.00 | 46 | |
An intracellular calcium antagonist, might have effects on calcium signaling pathways involving CHP2. | ||||||